Translation groups are working groups that develop preclinical models from experimental results to prepare clinical trials or validate hypotheses from basic science results using patient samples/patient data. Particular attention is paid to the development of predictive markers (translation group biomarkers). With these, it will be possible to predict the response to forms of therapy far better than today. As a result, unnecessary therapies and side effects will be avoided and resources will be used more efficiently. The establishment of the translation groups within the BZKF network is currently under construction.